![Frontiers | Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study Frontiers | Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study](https://www.frontiersin.org/files/Articles/1165471/fendo-14-1165471-HTML/image_m/fendo-14-1165471-g001.jpg)
Frontiers | Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study
![FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News](https://www.notebookcheck.net/fileadmin/Notebooks/News/_nc3/Eversense_CGM_system_90_day_now_180_days_blood_glucose_drdNBC.jpg)
FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News
![In the News... Testing new T1D treatments, 6-month CGM launches in the US, Dexcom One and more! - Diabetes Connections In the News... Testing new T1D treatments, 6-month CGM launches in the US, Dexcom One and more! - Diabetes Connections](https://diabetes-connections.com/wp-content/uploads/2022/04/In-the-News...-3.png)